UNITY Biotechnology, Inc. Reports Third Quarter 2018 Financial Results
07 nov. 2018 16h05 HE
|
Unity Biotechnology, Inc.
SAN FRANCISCO, Nov. 07, 2018 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or...
UNITY Biotechnology, Inc. to Announce Third Quarter 2018 Financial Results
31 oct. 2018 16h05 HE
|
Unity Biotechnology, Inc.
SAN FRANCISCO, Oct. 31, 2018 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) (NASDAQ:UBX), a biotechnology company developing therapeutics to extend healthspan by slowing, halting or...
UNITY Biotechnology, Inc. to Participate in the Cantor Fitzgerald Annual Global Healthcare Conference
24 sept. 2018 16h05 HE
|
Unity Biotechnology, Inc.
SAN FRANCISCO, Sept. 24, 2018 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) (NASDAQ:UBX), a biotechnology company developing therapeutics to extend healthspan by slowing, halting or...
UNITY Biotechnology, Inc. to Participate in the Morgan Stanley 16th Annual Global Healthcare Conference
05 sept. 2018 16h05 HE
|
Unity Biotechnology, Inc.
SAN FRANCISCO, Sept. 05, 2018 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) (NASDAQ:UBX), a biotechnology company developing therapeutics to extend healthspan by slowing, halting or...
UNITY Biotechnology, Inc. Reports Second Quarter 2018 Financial Results
09 août 2018 16h05 HE
|
Unity Biotechnology, Inc.
SAN FRANCISCO, Aug. 09, 2018 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) (NASDAQ:UBX), a biotechnology company developing therapeutics to extend healthspan by slowing, halting or...
UNITY Biotechnology, Inc. to Announce Second Quarter 2018 Financial Results
31 juil. 2018 16h05 HE
|
Unity Biotechnology, Inc.
SAN FRANCISCO, Calif., July 31, 2018 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) (NASDAQ:UBX), a biotechnology company developing therapeutics to extend healthspan by slowing, halting or...
UNITY Biotechnology, Inc. Announces First Patient Treated in UBX0101 Phase 1 Trial for Osteoarthritis of the Knee
25 juin 2018 08h00 HE
|
Unity Biotechnology, Inc.
SAN FRANCISCO, June 25, 2018 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) (NASDAQ:UBX), a biotechnology company developing therapeutics to extend healthspan by slowing, halting or...
UNITY Biotechnology, Inc. Added to Russell 3000®, 2000® and MicroCap® Indexes
13 juin 2018 16h00 HE
|
Unity Biotechnology, Inc.
SAN FRANCISCO, June 13, 2018 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) (NASDAQ:UBX), a biotechnology company developing therapeutics to extend healthspan by slowing, halting or...
UNITY Biotechnology, Inc. Reports First Quarter 2018 Financial Results
07 juin 2018 17h00 HE
|
Unity Biotechnology, Inc.
SAN FRANCISCO, June 07, 2018 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) (NASDAQ:UBX), a biotechnology company developing therapeutics to extend healthspan by slowing, halting or...
UNITY Biotechnology, Inc. to Participate in the Goldman Sachs 39th Annual Global Healthcare Conference
05 juin 2018 16h05 HE
|
Unity Biotechnology, Inc.
SAN FRANCISCO, June 05, 2018 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) (NASDAQ:UBX), a biotechnology company developing therapeutics to extend healthspan by slowing, halting or...